Laurus Labs Limited

NSEI:LAURUSLABS 주식 리포트

시가총액: ₹729.3b

Laurus Labs 향후 성장

Future 기준 점검 3/6

Laurus Labs (는) 각각 연간 19.1% 및 13.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 18.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 18.7% 로 예상됩니다.

핵심 정보

19.1%

이익 성장률

18.39%

EPS 성장률

Pharmaceuticals 이익 성장16.6%
매출 성장률13.3%
향후 자기자본이익률18.73%
애널리스트 커버리지

Good

마지막 업데이트20 May 2026

최근 향후 성장 업데이트

분석 기사 • Jan 28

Results: Laurus Labs Limited Beat Earnings Expectations And Analysts Now Have New Forecasts

Laurus Labs Limited ( NSE:LAURUSLABS ) just released its quarterly report and things are looking bullish. It was...

Recent updates

내러티브 업데이트 • Apr 30

LAURUSLABS: Upcoming Dividend Decision And Stable Assumptions Will Support Future Upside

Analysts have kept the Laurus Labs fair value estimate unchanged at ₹1,270, with small tweaks to revenue growth, profit margin and P/E assumptions. These reflect updated models rather than a shift in overall conviction.
내러티브 업데이트 • Apr 15

LAURUSLABS: Stronger Fundamentals And Upcoming Board Decisions Will Support Upside

Analysts have slightly reduced the Laurus Labs fair value estimate to ₹1,270 from ₹1,280 after updating assumptions on revenue growth, margins, and future P/E, while keeping the overall risk profile unchanged. Analyst Commentary Recent Street research on a different company, Laureate Education, still gives you a sense of how bullish analysts may think when they see improving fundamentals, supportive macro factors, or cleaner execution.
내러티브 업데이트 • Apr 01

LAURUSLABS: Currency And Execution Uncertainties Will Likely Cap Margin Upside

Analysts have made a small upward tweak to the Laurus Labs fair value estimate, with the price target moving from ₹540.28 to ₹543.09. This reflects updated assumptions on revenue growth and profitability.
내러티브 업데이트 • Mar 18

LAURUSLABS: Higher Margin Assumptions Will Likely Struggle Against Execution Risks

Narrative Update on Laurus Labs The updated analyst price target for Laurus Labs moves from about ₹330 to roughly ₹540. Analysts point to revised assumptions for margins and future P/E, along with broadly steady growth expectations, as key drivers of the change.
내러티브 업데이트 • Mar 04

LAURUSLABS: Steady Fair Value And Solid Fundamentals Will Support Upside

Analysts have kept their price target for Laurus Labs steady at ₹1,280, reflecting small adjustments to assumptions on discount rate, revenue growth, profit margin and future P/E. These changes are consistent with recent Street research, where targets shifted within a relatively tight range and analysts cited solid fundamentals alongside mixed near term signals.
내러티브 업데이트 • Feb 18

LAURUSLABS: Future Returns Will Rely On Confidence In Elevated P E Assumptions

Narrative Update: Laurus Labs Analyst Price Target Analysts have maintained their Laurus Labs price target at ₹913.47, citing largely unchanged assumptions around revenue, profit margins, discount rate, and forward P/E as the basis for keeping fair value steady. Analyst Commentary Analysts covering Laurus Labs are using a similar playbook to recent work on other education and healthcare names, where price targets are adjusted mainly on valuation inputs rather than big changes in growth assumptions.
내러티브 업데이트 • Feb 03

LAURUSLABS: Future Returns Will Depend On Confidence In Rich P E Assumptions

Analysts have lifted their fair value estimate for Laurus Labs from ₹863.13 to ₹913.47, citing slightly higher assumptions for revenue growth, profit margins and future P/E multiples, consistent with recent upward target revisions seen in related Street research. Analyst Commentary Bullish analysts point to the higher fair value estimate of ₹913.47 as support for a more constructive view on Laurus Labs, even though inputs are only slightly adjusted.
분석 기사 • Jan 28

Results: Laurus Labs Limited Beat Earnings Expectations And Analysts Now Have New Forecasts

Laurus Labs Limited ( NSE:LAURUSLABS ) just released its quarterly report and things are looking bullish. It was...
분석 기사 • Jan 25

Laurus Labs Limited's (NSE:LAURUSLABS) Popularity With Investors Is Under Threat From Overpricing

With a price-to-earnings (or "P/E") ratio of 65.1x Laurus Labs Limited ( NSE:LAURUSLABS ) may be sending very bearish...
내러티브 업데이트 • Jan 20

LAURUSLABS: Future Returns Will Depend On Rich P E Assumptions Holding

Analysts have lifted their price target for Laurus Labs to ₹863 from about ₹822, reflecting updated assumptions on fair value, profit margins, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts view the higher price target as a sign that current assumptions on Laurus Labs' fair value leave room for upside if the company executes consistently on profitability.
내러티브 업데이트 • Jan 06

LAURUSLABS: Interim Dividend And Higher P E Multiple Will Support Upside

Analysts have raised their price target on Laurus Labs from ₹1,025 to ₹1,280, citing updated assumptions for revenue growth, profit margins, and a higher future P/E multiple. What's in the News The Board of Directors approved an interim dividend of ₹0.80 per equity share of face value ₹2 for the 2025-26 financial year at the meeting held on October 23, 2025 (company filing).
내러티브 업데이트 • Dec 21

LAURUSLABS: Interim Dividend May Not Offset Softer Margins Ahead

Analysts have moderately raised their price target on Laurus Labs from ₹303.09 to ₹330.21, citing a slightly higher justified valuation multiple that more than offsets their marginally softer assumptions on revenue growth and profit margins. What's in the News The Board approved an interim dividend of INR 0.80 per equity share (40 percent of the face value of INR 2) for FY 2025-26, signaling confidence in cash flows and shareholder returns (company filing).
내러티브 업데이트 • Dec 07

LAURUSLABS: Future Returns Will Likely Hinge On Managing Execution Risks

Analysts have modestly increased their price target for Laurus Labs while maintaining fair value at ₹821.93, citing expectations of sustained earnings growth supported by a solid balance sheet, margin expansion, and revenue momentum from new market opportunities. Analyst Commentary Street research on comparable growth stories in the education and healthcare sectors highlights themes that are directly relevant for Laurus Labs, particularly around how markets price in multi year earnings expansion, balance sheet strength, and scalability in new markets.
내러티브 업데이트 • Nov 23

LAURUSLABS: Future Revenue Upside May Be Limited By Execution Risks

Analysts have raised their price target for Laurus Labs slightly, from ₹815.86 to ₹821.93. They cite expectations of stronger revenue growth supported by a robust balance sheet and expanding opportunities in new markets.
내러티브 업데이트 • Nov 04

LAURUSLABS: Margin Pressures From Rising Input Costs Will Weigh On Earnings

Analysts have raised their fair value price target for Laurus Labs from ₹724.14 to ₹815.86. They cite increased profitability outlook and sustained margin growth as key drivers for the revision.
분석 기사 • Oct 30

Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.80

Laurus Labs Limited ( NSE:LAURUSLABS ) will pay a dividend of ₹0.80 on the 22nd of November. Even though the dividend...
내러티브 업데이트 • Oct 21

Analysts Cite Growth Momentum and Strong Balance Sheet in Raising Laurus Labs Valuation Estimates

Analysts have raised their fair value estimate for Laurus Labs from ₹694.85 to ₹724.14. They cite continued revenue growth momentum and a strong balance sheet as key drivers for this upward revision.
분석 기사 • Oct 19

With Laurus Labs Limited (NSE:LAURUSLABS) It Looks Like You'll Get What You Pay For

Laurus Labs Limited's ( NSE:LAURUSLABS ) price-to-sales (or "P/S") ratio of 8.2x may look like a poor investment...
분석 기사 • Aug 31

Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Jul 20

Revenues Tell The Story For Laurus Labs Limited (NSE:LAURUSLABS) As Its Stock Soars 28%

The Laurus Labs Limited ( NSE:LAURUSLABS ) share price has done very well over the last month, posting an excellent...
분석 기사 • Jun 11

Investors Shouldn't Be Too Comfortable With Laurus Labs' (NSE:LAURUSLABS) Earnings

Unsurprisingly, Laurus Labs Limited's ( NSE:LAURUSLABS ) stock price was strong on the back of its healthy earnings...
User avatar
새로운 내러티브 • Jan 26

CDMO Expansion May Impact Near-Term Margins But Pave Way For Future Revenue Streams

Heavy investment in CDMO and microbial precision initiatives may lead to revenue delays and short-term margin compression due to underutilized assets.

이익 및 매출 성장 예측

NSEI:LAURUSLABS - 애널리스트 향후 추정치 및 과거 재무 데이터 (INR Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
3/31/2029102,62115,8046,08816,6696
3/31/202890,21513,7163,69515,86014
3/31/202778,92811,0741,23413,65511
3/31/202668,1298,8885,53616,235N/A
12/31/202567,2168,433N/AN/AN/A
9/30/202563,5846,8407,69616,375N/A
6/30/202559,2865,088N/AN/AN/A
3/31/202555,5403,583-3936,017N/A
12/31/202452,7332,003N/AN/AN/A
9/30/202450,5321,311-3,2772,489N/A
6/30/202450,5401,482N/AN/AN/A
3/31/202450,4081,606-1266,657N/A
12/31/202349,8211,879N/AN/AN/A
9/30/202353,3203,6782,87012,248N/A
6/30/202356,8345,637N/AN/AN/A
3/31/202360,4067,901379,939N/A
12/31/202260,8459,176N/AN/AN/A
9/30/202255,6848,683138,393N/A
6/30/202251,9608,374N/AN/AN/A
3/31/202249,3568,2753439,111N/A
12/31/202149,2278,937N/AN/AN/A
9/30/202151,82310,128-1,7057,112N/A
6/30/202151,17710,532N/AN/AN/A
3/31/202148,1359,8364427,330N/A
12/31/202042,4077,971N/AN/AN/A
9/30/202036,8195,9771,5485,427N/A
6/30/202032,5554,120N/AN/AN/A
3/31/202028,3172,5531,2523,474N/A
12/31/201926,2771,883N/AN/AN/A
9/30/201924,2761,326N/A3,538N/A
6/30/201923,035923N/AN/AN/A
3/31/201922,919938N/A2,977N/A
12/31/201822,170957N/AN/AN/A
9/30/201821,6651,127N/AN/AN/A
6/30/201821,1681,453N/AN/AN/A
3/31/201820,5621,676N/A3,425N/A
12/31/201719,6871,917N/AN/AN/A
9/30/201719,9542,019N/AN/AN/A
6/30/201719,7332,014N/AN/AN/A
3/31/201719,0461,881N/A3,320N/A
3/31/201617,7761,337N/A1,820N/A

애널리스트 향후 성장 전망

수입 대 저축률: LAURUSLABS 의 연간 예상 수익 증가율(19.1%)이 saving rate(6.9%)보다 높습니다.

수익 vs 시장: LAURUSLABS 의 연간 수익(19.1%)이 Indian 시장(16.3%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 수익: LAURUSLABS 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: LAURUSLABS 의 수익(연간 13.3%)이 Indian 시장(연간 10.8%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: LAURUSLABS 의 수익(연간 13.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: LAURUSLABS의 자본 수익률은 3년 후 18.7%로 낮을 것으로 예상됩니다.

성장 기업 찾아보기

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/22 12:17
종가2026/05/22 00:00
수익2026/03/31
연간 수익2026/03/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Laurus Labs Limited는 22명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Rohit Bhat360 ONE Capital Market Private Limited
Ashwin MehtaAmbit Capital
null nullAntique Stockbroking Ltd.